tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Sana Biotechnology EVP and President of R&D Resigns

Sana Biotechnology EVP and President of R&D Resigns

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Sana Biotechnology (SANA) just unveiled an announcement.

Douglas Williams, Ph.D., has voluntarily resigned from his roles as Executive Vice President and President of Research and Development at Sana Biotechnology, Inc., effective April 18, 2024. His departure is for personal reasons and does not stem from any disputes with the company.

See more insights into SANA stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1